Stability of the Clostridium botulinum type a neurotoxin complex:: An empirical phase diagram based approach

被引:17
作者
Brandau, Duane T.
Joshi, Sangeeta B.
Smalter, Aaron M.
Kim, Seonyoung
Steadman, Bryan
Middaugh, C. Russell
机构
[1] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA
[2] LigoCyte Pharmaceut Inc, Bozeman, MT 59718 USA
[3] Monsanto Co, St Louis, MO 63167 USA
关键词
botulinum toxin A; physical stability; phase diagram;
D O I
10.1021/mp0601244
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Clostridium botulinum type A neurotoxin (BoNT/A complex) is of great interest to the pharmaceutical industry. The drug itself is a natural complex of the toxin and a number of associated proteins. Surprisingly, relatively little is known about the exact structure and stability of the 900 kD(a) BoNT/A complex and its component proteins with the exception of the 150 kDa neurotoxin. In this study we describe the relative stability of the BoNT/A complex, the neurotoxin, and its associated proteins over a wide range of temperature and pH employing circular dichroism, intrinsic and 8-anilino-1-naphthalene sulfonate (ANS) fluorescence, and static light scattering. The data suggest a strong stabilizing effect of the associated proteins on the neurotoxin component. This data is compiled into empirical phase diagrams which permit the simultaneous visualization of multiple data sets over a wide range of conditions.
引用
收藏
页码:571 / 582
页数:12
相关论文
共 18 条
[1]   A molecular basis underlying differences in the toxicity of botulinum serotypes A and E [J].
Bajohrs, M ;
Rickman, C ;
Binz, T ;
Davletov, B .
EMBO REPORTS, 2004, 5 (11) :1090-1095
[2]   Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species [J].
Chen, F ;
Kuziemko, GM ;
Stevens, RC .
INFECTION AND IMMUNITY, 1998, 66 (06) :2420-2425
[3]   Botulism: Update and review [J].
Cherington, M .
SEMINARS IN NEUROLOGY, 2004, 24 (02) :155-163
[4]   Solution behavior of IFN-β-1a:: An empirical phase diagram based approach [J].
Fan, HH ;
Ralston, J ;
Dibiase, M ;
Faulkner, E ;
Middaugh, CR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (09) :1893-1911
[5]   Recent advances in infant botulism [J].
Fox, CK ;
Keet, CA ;
Strober, JB .
PEDIATRIC NEUROLOGY, 2005, 32 (03) :149-154
[6]   A protease-resistant novel hemagglutinin purified from type A Clostridium botulinum [J].
Fu, FN ;
Sharma, SK ;
Singh, BR .
JOURNAL OF PROTEIN CHEMISTRY, 1998, 17 (01) :53-60
[7]   STRUCTURAL ENERGETICS OF THE MOLTEN GLOBULE STATE [J].
HAYNIE, DT ;
FREIRE, E .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1993, 16 (02) :115-140
[8]  
Hunt T, 2006, MOVEMENT DISORD, V21, pS348
[9]   Molecular composition of Clostridium botulinum type A progenitor toxins [J].
Inoue, K ;
Fujinaga, Y ;
Watanabe, T ;
Ohyama, T ;
Takeshi, K ;
Moriishi, K ;
Nakajima, H ;
Inoue, K ;
Oguma, K .
INFECTION AND IMMUNITY, 1996, 64 (05) :1589-1594
[10]  
KNOX J N, 1970, Infection and Immunity, V1, P205